Current Developments in Pharmacogenomics of Multiple Sclerosis

被引：5
|
作者：
Carlson, Rebecca J. [1 ,2 ]
Doucette, J. Ronald [2 ,3 ,4 ]
Nazarali, Adil J. [1 ,4 ,5 ]
机构：
[1] Univ Saskatchewan, Coll Pharm & Nutr, Mol Cell Biol Lab, Saskatoon, SK S7N 5C9, Canada
[2] Univ Saskatchewan, Neurosci Res Grp, Saskatoon, SK S7N 5C9, Canada
[3] Univ Saskatchewan, Dept Anat & Cell Biol, Coll Med, Saskatoon, SK S7N 5C9, Canada
[4] City Hosp, Cameco Multiple Sclerosis Neurosci Res Ctr, Saskatoon, SK, Canada
[5] Univ Saskatchewan, Neurosci Res Grp, Saskatoon, SK S7N 5E2, Canada
来源：
CELLULAR AND MOLECULAR NEUROBIOLOGY | 2014年 / 34卷 / 08期
基金：
加拿大健康研究院;
关键词：
Pharmacogenomics; Multiple sclerosis; Interferon-beta; Glatiramer acetate; SNPs; Genome-wide association studies; INTERFERON-BETA THERAPY; GLATIRAMER ACETATE; GENE; SUSCEPTIBILITY; POLYMORPHISMS; MARKERS;
D O I：
10.1007/s10571-014-0095-0
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
Pharmacogenomics has a significant potential to impact how we treat diseases. It involves targeting genetically identifiable populations with therapeutic interventions that promises to yield immediate positive health outcomes with lower or no side effects. The 'trial and error' method of treatment will no longer be necessary with the successful implementation of personalized medicine. The following is an overview of some new developments in pharmacogenomics of multiple sclerosis, and how it has the potential to improve future treatment.
引用
收藏
页码：1081 / 1085
页数：5
相关论文
共 50 条
  • [31] Current therapies for multiple sclerosis
    不详
    MOLECULAR IMMUNOLOGY, 2003, 39 (17-18) : 1101 - 1101
  • [32] Current treatments for multiple sclerosis
    Young, C. A.
    JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF EDINBURGH, 2007, 37 (02): : 117 - 119
  • [33] Current aspects of multiple sclerosis
    Fröscher, W
    NERVENHEILKUNDE, 2005, 24 (04) : 251 - 252
  • [34] Current treatment of multiple sclerosis
    Gout, O.
    Bensa, C.
    Assouad, R.
    REVUE DE MEDECINE INTERNE, 2010, 31 (08): : 575 - 580
  • [35] Current treatments for multiple sclerosis
    Kernich, CA
    NEUROLOGIST, 2005, 11 (02) : 137 - 138
  • [36] Current therapy of multiple sclerosis
    Bartosik-Psujek, Halina
    AKTUALNOSCI NEUROLOGICZNE, 2009, 9 (02): : 126 - 131
  • [37] Current Perspectives on Multiple Sclerosis
    Hvizdos, Andrew J.
    Mosler, Charles R.
    US PHARMACIST, 2016, 41 (01) : 22 - 26
  • [38] RECENT DEVELOPMENTS IN MULTIPLE-SCLEROSIS RESEARCH
    POSER, S
    NERVENARZT, 1979, 50 (10): : 611 - 625
  • [39] Recent developments in drug therapy for multiple sclerosis
    Smith, PF
    Darlington, CL
    MULTIPLE SCLEROSIS, 1999, 5 (02): : 110 - 120
  • [40] The neuropsychiatry of multiple sclerosis: a review of recent developments
    Ghaffar, Omar
    Feinstein, Anthony
    CURRENT OPINION IN PSYCHIATRY, 2007, 20 (03) : 278 - 285
12345